ArticleACS medicinal chemistry letters2018

Discovery of a First-in-Class Gut-Restricted RET Kinase Inhibitor as a Clinical Candidate for the Treatment of IBS.

Hilary Schenck Eidam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.